Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal morphine + dexmedetomidine for severe cancer pain in advanced lung cancer
ChiCTR2500096912Phase 4Not yet recruiting
- Sponsor
- Shanghai East Hospital
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in bronchial carcinoma and cancer pain comparing intrathecal morphine + dexmedetomidine with Control: intrathecal morphine alone (2 arms). Primary endpoint: Numeric analogue scale (NRS) pain score. Planned start Feb 2025; status: not yet recruiting.
02
Drugs
morphinedexmedetomidine
03
Conditions
bronchial carcinomacancer pain
Beyond the preview
Go deeper on ChiCTR2500096912.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500096912.